Bavarian Says It Can Meet Mpox Shot Demand, Shares Jump (1)

Bavarian Nordic A/S, one of the few companies with an approved mpox vaccine, says it will be able to meet the immunization needs of African nations in the throes of an mpox outbreak.

Shares in the Danish company surged as much as 17% in early Thursday trading in Copenhagen, extending a 12% rise the day before, after it said it can provide 10 million doses of its vaccine to African countries by the end of 2025.

“We have inventory and we have the capabilities. What we’re missing are the orders,” Bavarian Nordic’s Chief Executive Officer Paul Chaplin said in ...